Sheba Medical Center, based in Israel, is recognized for its advanced treatment of metastatic melanoma through TIL (Tumor-Infiltrating Lymphocytes) Immunotherapy. This specialized treatment is particularly beneficial for patients who have not responded well to traditional cancer therapies. The success rate of TIL therapy at Sheba Medical Center is noteworthy, with about half of the treated patients showing positive improvements and a significant proportion being effectively cured of their melanoma.
TIL Therapy
- 18 years of clinical experience in metastatic melanoma
- 2nd largest center in the world for treatment of metastatic melanoma
- 200+ treated Melanoma patients
- Salvage therapy for patient refractory to standard treatments
- Large collection of patient samples (TIL, tumor cells, paraffin blocks, serum, PBMC, clinical data)
- TIL therapy can induce durable effect in metastatic melanoma
- Patients may be disease free after a single treatment
- Responding patients can achieve cure
What is TIL therapy for metastatic melanoma? >>
How much does TIL melanoma treatment cost?
